Remove 2001 Remove Drug Pricing Remove Pharmaceutical Manufacturing
article thumbnail

Preliminary Injunction Decision in Chambers of Commerce Case Provides First Insights Into Merits of Medicare Negotiations Cases

FDA Law Blog: Biosimilars

By Faraz Siddiqui — Last week, a federal court in Ohio denied a preliminary injunction motion by four Chambers of Commerce in their lawsuit against the Medicare Drug Price Negotiation Program. Engler , a 2001 decision by the Sixth Circuit Court of Appeals.